Arylamine N-acetyltransferase (NAT2) genotypes in a Turkish population
- PMID: 9295061
- DOI: 10.1097/00008571-199708000-00008
Arylamine N-acetyltransferase (NAT2) genotypes in a Turkish population
Abstract
A group of 303 unrelated Turkish subjects from south-east Anatolia was genotyped for seven NAT2 mutations by polymerase chain reaction-restriction fragment length polymorphism. Genotypes associated with slow acetylation were identified in 57.4% (95%-confidence limits, 51.6%-63.1%). Allele frequencies were NAT2*4 (wild type, 23.1%), *5A (1.3%), *5B (35.6%), *5C (4.8%), *6A (30.5%), *7B (4.5%), and *12A (0.2%). A mutation G191A was not detected. Ambiguous mutation linkages were checked by molecular genetic linkage analysis and DNA sequencing. NAT2-alleles in Turks are similarly distributed as in Middle European ethnicities.
Similar articles
-
Determination and allelic allocation of seven nucleotide transitions within the arylamine N-acetyltransferase gene in the Polish population.Clin Pharmacol Ther. 1996 Apr;59(4):376-82. doi: 10.1016/S0009-9236(96)90104-6. Clin Pharmacol Ther. 1996. PMID: 8612380
-
Studies on N-Acetyltransferase (NAT2) Genotype Relationships in Emiratis: Confirmation of the Existence of Phenotype Variation among Slow Acetylators.Ann Hum Genet. 2017 Sep;81(5):190-196. doi: 10.1111/ahg.12198. Epub 2017 Jun 27. Ann Hum Genet. 2017. PMID: 28653770
-
Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity.Am J Hum Genet. 1995 Sep;57(3):581-92. Am J Hum Genet. 1995. PMID: 7668286 Free PMC article.
-
N-acetyltransferase (NAT2) polymorphism and breast cancer susceptibility: a lack of association in a case-control study of Turkish population.Int J Toxicol. 2004 Jan-Feb;23(1):25-31. doi: 10.1080/10915810490275053. Int J Toxicol. 2004. PMID: 15162844
-
Arylamine N-acetyltransferase activity in man.Drug Metab Rev. 1999 May;31(2):489-502. doi: 10.1081/dmr-100101932. Drug Metab Rev. 1999. PMID: 10335449 Review. No abstract available.
Cited by
-
Association between the N-acetylation genetic polymorphism and bronchial asthma.Br J Clin Pharmacol. 2002 Dec;54(6):671-4. doi: 10.1046/j.1365-2125.2002.01670.x. Br J Clin Pharmacol. 2002. PMID: 12492617 Free PMC article.
-
Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population.Eur J Clin Pharmacol. 2003 Aug;59(4):303-12. doi: 10.1007/s00228-003-0606-2. Epub 2003 Jul 15. Eur J Clin Pharmacol. 2003. PMID: 12879168
-
CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis.Eur J Clin Pharmacol. 2006 Jun;62(6):423-9. doi: 10.1007/s00228-006-0111-5. Epub 2006 Apr 27. Eur J Clin Pharmacol. 2006. PMID: 16770646
-
Inferring haplotypes at the NAT2 locus: the computational approach.BMC Genet. 2005 Jun 2;6:30. doi: 10.1186/1471-2156-6-30. BMC Genet. 2005. PMID: 15932650 Free PMC article.
-
N-acetyltransferase 1 and 2 gene sequence variants and risk of head and neck cancer.Mol Biol Rep. 2010 Oct;37(7):3217-26. doi: 10.1007/s11033-009-9905-8. Epub 2009 Nov 8. Mol Biol Rep. 2010. PMID: 19898993
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources